All In Biotech

Free tool

FAERS Monitor: Augmentin '875'

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050720 or its brand name (Augmentin '875', Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.

Reports

4,398

Serious

3,700

84% of reports

Hospitalization

2,007

Death reported

431

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea357
  • dyspnoea356
  • pyrexia257
  • drug ineffective242
  • nausea241
  • fatigue237
  • pneumonia225
  • pruritus223
  • rash218
  • pain214
  • vomiting208
  • headache194
  • cough187
  • asthma179
  • condition aggravated178

Reports by year received

View as table
YearReports
2004131
2005139
200641
200745
200868
2009302
2010370
2011451
2012393
20139
201457
2015143
2016205
2017206
2018326
2019260
2020237
2021165
2022171
2023162
2024203
2025192
2026121

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,761 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
asthmaSignal1797.66.61,021
pyrexiaSignal2573.63.2477
pneumoniaSignal2253.32.9369
coughSignal1873.22.8283
dyspnoeaSignal3563.02.7488
condition aggravatedSignal1782.82.4207
pruritusSignal2232.82.4256
diarrhoeaSignal3572.62.4375
rashSignal2182.42.1179
vomitingSignal2082.11.9124
pain2141.71.558
headache1941.51.331
nausea2411.51.335
fatigue2371.51.335
drug ineffective2420.90.84

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.